ClinicalTrials.govpublic full text
Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age
respiratory viral infections, respiratory syncytial virus infections, parainfluenza virus 3, human, lower respiratory tract illness, rsv and piv3 infection, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 878885
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.